Prestwick3_000009

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

57 API Suppliers, 31 USDMF, 22 CEP/COS, 8 JDMF, 10 EU WC, 17 KDMF, 17 NDC API, 24 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Formulations

3052 Dossiers, 874 FDA Orange Book, 1374 Europe, 235 Canada, 23 Australia, 161 South Africa, 385 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 25MG;25MG
TABLET;ORAL - 50MG;50MG
CAPSULE;ORAL - 25MG;37.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 25MG;37.5MG
TABLET;ORAL - 50MG;75MG
TABLET;ORAL - 10MG;25MG
TABLET;ORAL - 5MG;12.5MG
TABLET;ORAL - 12.5MG;10MG
TABLET;ORAL - 12.5MG;20MG
TABLET;ORAL - 25MG;20MG
TABLET;ORAL - 12.5MG;100MG
TABLET;ORAL - 12.5MG;50MG
TABLET;ORAL - 25MG;100MG
CAPSULE;ORAL - 12.5MG
TABLET;ORAL - 12.5MG;150MG
TABLET;ORAL - 12.5MG;300MG
TABLET;ORAL - 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 12.5MG;160MG
TABLET;ORAL - 12.5MG;320MG
TABLET;ORAL - 12.5MG;80MG
TABLET;ORAL - 25MG;160MG
TABLET;ORAL - 25MG;320MG
TABLET;ORAL - 16MG;12.5MG
TABLET;ORAL - 32MG;12.5MG
TABLET;ORAL - 32MG;25MG
TABLET;ORAL - 12.5MG;40MG
TABLET;ORAL - 12.5MG;80MG
TABLET;ORAL - 25MG;80MG
TABLET;ORAL - 12.5MG;20MG
TABLET;ORAL - 12.5MG;40MG
TABLET;ORAL - 25MG;40MG
TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 10MG BASE;12.5MG;160MG
TABLET;ORAL - EQ 10MG BASE;25MG;160MG
TABLET;ORAL - EQ 10MG BASE;25MG;320MG
TABLET;ORAL - EQ 5MG BASE;12.5MG;160MG
TABLET;ORAL - EQ 5MG BASE;25MG;160MG
TABLET;ORAL - 25MG
TABLET;ORAL - 50MG

RELATED EXCIPIENT COMPANIES

Suppliers, 39 Kerry, 39 BASF, 29 Roquette, 25 SPI Pharma, 20 Microlex e.U, 16 Seppic, 14 Nanjing Well Pharmaceutical, 13 Gangwal Healthcare, 13 Gangwal Chemicals, 13 Corel Pharma Chem, 12 Sigachi Industries, 12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Actylis, 9 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Boai NKY Pharmaceuticals Ltd, 7 DFE Pharma, 7 Ideal Cures Pvt Ltd, 6 Lonza Capsugel, 6 Prachin Chemical, 6 Vasa Pharmachem, 5 Ingredion Pharma Solutions, 5 Pharmatrans-Sanaq, 4 Kima Chemical, 4 ACG Worldwide, 4 Alcedo Pharmachem, 4 DKSH, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 3 Finar, 3 Clariant, 3 Jai Radhe Sales, 3 Rochem International Inc, 2 Seqens, 2 Shijiazhuang Huaxu Pharmaceutical, 2 Pfanstiehl, 2 Nanjing Bold Chemical, 2 Qualicaps, 2 Nomisma Healthcare, 1 Avesta Pharma, 1 Zhejiang Huakang Pharmaceutical, 1 Minakem, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Aeon Procare, 1 Huzhou Sunflower Pharmaceutical Co. Ltd, 1 Vertellus, 1 Evonik, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Doshion Polyscience, 1 NEWEDGE Overseas, 1 Chynops Pharma, 1 Pharm-RX Chemical

EXCIPIENTS BY APPLICATIONS

105 Fillers, Diluents & Binders, 60 Coating Systems & Additives, 55 Direct Compression, 50 Disintegrants & Superdisintegrants, 39 Granulation, 38 Controlled & Modified Release, 37 Solubilizers, 37 Lubricants & Glidants, 32 Film Formers & Plasticizers, 31 Thickeners and Stabilizers, 29 Taste Masking, 29 Topical, 28 Parenteral, 21 Chewable & Orodispersible Aids, 19 Co-Processed Excipients, 10 API Stability Enhancers, 10 Emulsifying Agents, 9 Empty Capsules, 6 Surfactant & Foaming Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin